KZA 0.00% 8.0¢ kazia therapeutics limited

Simcere Therapeutics

  1. 1,120 Posts.
    lightbulb Created with Sketch. 762
    Simcere Therapeutics - R&D Pipeline
    SIM0395 (PI3K/mTOR) Phase111 Glioblastoma (GBM Agile study)
    Simcere and Kazia waiting for Chinese regulator's approval to enrol first patient in the study.

    Regards.

    https://hotcopper.com.au/data/attachments/4519/4519103-4dd50c7b83df46139708f2a7fdd06f21.jpg
 
watchlist Created with Sketch. Add KZA (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.